BioMed Research International

Effects of Microbiota on Cancer Immune Responses and Immunotherapy


Publishing date
01 Sep 2022
Status
Published
Submission deadline
13 May 2022

Lead Editor

1Guangzhou University, Guangzhou, China

2The Research Institute in Oncology and Hematology, Winnipeg, Canada

3McMaster University, Hamilton, Canada

4Universiti Malaysia Sabah, Kota Kinabalu, Malaysia


Effects of Microbiota on Cancer Immune Responses and Immunotherapy

Description

Microbiota collectively refers to all microorganisms living in a defined environment such as on the skin or in the intestinal tract, mouth, vagina, and eyes, including bacteria, archaea, fungi, and viruses. The largest population of microorganisms in the human body locates in the intestine and is called the gut or intestinal microbiota. Intestinal microbes are involved in a variety of physiological functions to maintain the health of the host, including providing nutrients and vitamins, catabolic drugs, and toxins, protecting the body from pathogens, promoting the development of the immune system, and maintaining epithelial mucosal homeostasis. The microbiota plays an important role in the physiology and pathology of the human body.

Cancer is a leading cause of death in the world. According to the World Health Organization (WHO), 10 million people died from cancer in 2020. It is estimated that 10-20% of cancers can be attributed to microbial infections. Many studies have demonstrated that the intestinal microbiota plays an important role in tumorigenesis. Microbes and their products can either have a direct carcinogenic effect or prevent the occurrence and development of cancer by regulating the production of circulating metabolites, inflammation, and immune responses. Cancer immunotherapy is a very promising therapy by boosting the immune system to kill cancer cells and suppress tumor growth. Microbiota on or in the human body can influence immune responses affecting immunotherapy.

This Special Issue invites original research and review articles which contribute to the understanding of the roles of microbiota in cancer immune responses and immunotherapy which may provide novel approaches in treating cancer.

Potential topics include but are not limited to the following:

  • Research and development of microbe-associated cancer immunotherapy
  • Mechanisms of microbiota disturbance in cancer immune responses
  • Correlation of microbiota with tumorigenesis
  • Screening and application of biomarkers of microbiota in cancer immune responses
  • Mechanisms of bacterial translocation causing cancer
  • Relationship between microbiota and mucosal immunity and its anticancer mechanism
  • Signaling pathways of microbiota regulating tumorigenesis
  • Mechanisms and applications of probiotic bacteria in immunotherapy

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 1740295
  • - Research Article

[Retracted] The Valuable Role of ARMC1 in Invasive Breast Cancer as a Novel Biomarker

Yunhao Gan | Fuxin Zhong | ... | Lingyu Li
  • Special Issue
  • - Volume 2022
  • - Article ID 2786147
  • - Research Article

[Retracted] Correlation of Carotid Artery Intima-Media Thickness with Calcium and Phosphorus Metabolism, Parathyroid Hormone, Microinflammatory State, and Cardiovascular Disease

Peng Huang | Junhua Tan | ... | Jie Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 5852451
  • - Review Article

[Retracted] Current Status of Malignant Tumors after Organ Transplantation

Bairu Shen | Zhuofei Cen | ... | Minqian Huang
  • Special Issue
  • - Volume 2022
  • - Article ID 7587398
  • - Research Article

[Retracted] Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes

Peng Cao | Bo Zhao | ... | Fan Li
  • Special Issue
  • - Volume 2022
  • - Article ID 8131531
  • - Research Article

[Retracted] Mechanism of Gegen Qinlian Decoction Regulating ABTB1 Expression in Colorectal Cancer Metastasis Based on PI3K/AKT/FOXO1 Pathway

Feng Li | Lili Chen | ... | Xiqiu Zhou
  • Special Issue
  • - Volume 2021
  • - Article ID 6388492
  • - Research Article

[Retracted] Evaluation of Liquid Biopsy in Patients with HER2-Positive Breast Cancer

Jianguo Huai | Ming Cao | ... | Xiaochun Lian
  • Special Issue
  • - Volume 2021
  • - Article ID 4896106
  • - Research Article

[Retracted] DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database

Mingchao Hu | Jianchun Gu | ... | Chungen Xing
  • Special Issue
  • - Volume 2021
  • - Article ID 6299472
  • - Research Article

[Retracted] Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma

Zheng Yao | Song Wen | ... | Yutang Chen
  • Special Issue
  • - Volume 2021
  • - Article ID 2033353
  • - Research Article

[Retracted] Efficacy of Aidi Injection and Brucea javanica Oil Emulsion Injection in Rectal Cancer during CapeOX Adjuvant Chemotherapy

Wenjun Meng | Xiaoge Zeng | ... | Lian Bai
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision128 days
Acceptance to publication21 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.